Latest Commercialisation News

Pure Hydrogen Corporation has secured a 15-year Potential Commercial Area approval and extended its ATP 927 permit for the Windorah Gas Project, marking a critical regulatory milestone ahead of its planned spinout.

Blue Star Helium has wrapped up its 2025 Galactica drilling campaign with strong results from six wells, setting the stage for commercial helium production in the second half of 2025.

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.

Omega Oil and Gas has extinguished a 3% royalty on its Queensland liquids production by paying TAG Oil US$1 million, clearing the way for greater commercial flexibility following promising flow tests at Canyon-1H.

Jade Gas Holdings has launched Mongolia’s inaugural horizontal Coal Bed Methane production wells at the Red Lake field, signaling a pivotal step in the country’s energy transition. The company also appoints Chris Whiteman as interim CEO amid strategic leadership changes.

Firebrick Pharma has unexpectedly withdrawn its planned share placement, raising questions about its capital strategy amid ongoing product launches.

Tivan Limited has received $150,000 in exploration grants from the Northern Territory Government to advance its promising Sandover Fluorite Project, supporting maiden drilling and metallurgical testwork.

Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.

Clarity Pharmaceuticals reports that its Cu-SARTATE diagnostic agent significantly outperforms the current standard in detecting neuroendocrine tumours, paving the way for a pivotal Phase III study.

State Gas Limited has settled a land access dispute at its Rolleston West Project, enabling the company to resume drilling and flow testing activities. This development paves the way for advancing coal seam gas production using innovative technologies.